A critical discovery in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This vital cancer protector protein is frequently disabled in various kinds of malignancies, leading uncontrolled https://bookmarkgenius.com/story21803437/mini-antibodies-reactivate-the-p53-protein-new-promising-pathway-for-malignant-management